Except for ATTR diagnosed with bone scintigraphy in the absence of a monoclonal dyscrasia (Gillmore et al. Circulation 2016), most patients with systemic amyloidosis require a biopsy to confirm amyloid deposition and the protein type in amyloid fibrils. The gene discussed is TTR; the disease is primary systemic amyloidosis.